Evidence map›Paper›PMID 40304936›Full record

ReviewCurrent medical science2025

Biomarker-Based Models Utilizing the Albumin-Fibrinogen Ratio Effectively Predict Peritoneal Metastasis in Patients with Gastric Cancer: A Retrospective Study.

Chun-Yang Shang, Xue-Pu Sun, Xue-Song Dong, Yang-Shuai Wang, Xiao Chen, Hai-Quan Qiao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chun-Yang ShangDepartment of Gastrosplenic Surgery, Harbin Medical University, Harbin, 150000, China.
Xue-Pu SunDepartment of Gastrosplenic Surgery, Harbin Medical University, Harbin, 150000, China.
Xue-Song DongDepartment of Gastrosplenic Surgery, Harbin Medical University, Harbin, 150000, China.
Yang-Shuai WangDepartment of Gastrosplenic Surgery, Harbin Medical University, Harbin, 150000, China.
Xiao ChenDepartment of Gastrosplenic Surgery, Harbin Medical University, Harbin, 150000, China.
Hai-Quan QiaoDepartment of Gastrosplenic Surgery, Harbin Medical University, Harbin, 150000, China. qiaohaiquan@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePeritoneal carcinomatosis (PC) is a common pattern of recurrence in gastric cancer patients and is associated with a poor prognosis. This study aimed to evaluate the predictive value of the albumin-fibrinogen ratio (AFR) for PC in patients with gastric cancer and to develop two preoperative prediction models.

methodsA total of 745 gastric cancer patients were included in this study. Preoperative AFR, along with other serum markers and clinical tumor characteristics, was assessed. Univariate and multivariate logistic regression analyses were performed to determine the odds ratios (ORs) and 95% confidence intervals (CIs) of the independent variables. Propensity score matching (PSM) was used to control for potential confounders, and one-way ANOVA was conducted to evaluate differences in distribution between groups. Two prediction models incorporating the independent predictive indicators were constructed and validated via receiver operating characteristic (ROC) curves.

resultsPoorly differentiated type (OR 2.679; P = 0.001), nondiffuse morphological type (OR 2.123; P = 0.040), BMI < 23.550 kg/m

conclusionsThe preoperative AFR serves as a useful indicator for predicting PC. Two reliable prediction models based on the AFR have been developed.

Indexed as

Biomarkers, TumorFibrinogenPeritoneal NeoplasmsSerum AlbuminStomach NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesROC CurveBiomarkers, TumorFibrinogenSerum AlbuminAlbumin-fibrinogen ratioGastric cancerPeritoneal carcinomatosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.